Levin Capital Strategies’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-55,000
Closed -$500K 424
2020
Q4
$500K Buy
+55,000
New +$425K 0.06% 149

Other funds holding NPTN

Levin Capital Strategies's NPTN Position: Q1 2021 in Review

Levin Capital Strategies sold out of NEOPHOTONICS CORP (NPTN) in Q1 2021, closing a stake of 60,000 shares — an estimated $545K sold.

Levin Capital Strategies first reported a position in NPTN in Q1 2018 and held it in 5 quarters. The position peaked at $545K in Q4 2020. 147 funds tracked by Wall St. Rank hold NPTN as of Q1 2021.

  • Levin Capital Strategies reported no remaining NEOPHOTONICS CORP position as of Q1 2021 after selling out during the quarter.
  • Levin Capital Strategies sold 60,000 NEOPHOTONICS CORP shares in Q1 2021, an estimated $545K.
  • Levin Capital Strategies first reported a position in NEOPHOTONICS CORP in Q1 2018 and held it in 5 quarters.
  • Levin Capital Strategies's NEOPHOTONICS CORP position peaked at $545K in Q4 2020.
  • 147 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2021.

Based on Levin Capital Strategies's 13F filing for Q1 2021, filed 5 May 2021.